MAKING GREAT DRUGS BETTER

News

Re-Vana Therapeutics Secure Innovate UK Grant

Re-Vana has developed a novel disruptive photocrosslinked proprietary biodegradable sustained release drug delivery implant, EyeLief. The implant will provide significant clinical benefits over current monthly intravitreal injections. Following injection into the eye,...

read more